Johnson & Johnson is suing a former oncology medical affairs employee who is now “employed by” Summit Therapeutics, alleging a massive and “malicious” stealing of trade secrets. More: J&J files trade secret lawsuit against former oncology employee linked to Summit
read moreA U.K. marketing watchdog has sided with Roche over Bayer after a spat between the companies boiled over, ruling that pre-license promotion of the German drugmaker’s eye med discredited the industry. More: Bayer found to have discredited pharma industry after
read moreThe CEO’s 2025 pay was a sizeable bump over the $24.6 million he collected in 2024, making for his second largest pay package since taking the helm in 2019. More: Pfizer CEO Albert Bourla collects .6M in 2025 pay following
read moreGSK has secured an FDA expansion for its respiratory syncytial virus vaccine, Arexvy, for adults ages 18 to 49 who are at increased risk of lower respiratory tract disease caused by the virus. The green light puts GSK on a
read moreFrom its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. And, for the twice-yearly pre-exposure prophylaxis medication—which Gilead Sciences has positioned as a key tool in the fight to end the HIV epidemic—“manufacturing
read moreSimtra BioPharma Solutions was issued a warning letter by the FDA after an inspection uncovered a number of problems at the CDMO’s production plant in Halle, Germany. More: FDA scolds CDMO Simtra with warning letter over contamination fumbles Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals